Intraoperative Low-dose Ketamine Infusion as the Main Analgesic in Burn Patients
Status:
Unknown status
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a low-dose ketamine infusion can be used as
the main intra-operative analgesic in different burn patients, and thereby reduce the total
intra-operative opioid requirement. Secondary objectives are to determine whether this
low-dose ketamine infusion will lengthen the amount of time to the first narcotic given in
the recovery room or ICU, and whether pain scores for awake patients will be lower
post-operatively.